Artificial Intelligence

Gestalt and DataPath: The companies are focused on making an impact on healthcare accessibility SPOKANE, Wash., Sept. 16, 2024 /PRNewswire/ -- Gestalt, a leader in AI-driven digital pathology solutions, is excited to announce its...

Dublin, 16th September 2024 — Deciphex today announced the launch of VICT3R, a groundbreaking initiative aimed at transforming nonclinical drug and chemical safety evaluation. VICT3R is a public-private partnership supported by the...

Nijmegen, the Netherlands – Aiosyn is proud to announce the first results of an independent clinical performance study conducted for its Aiosyn Mitosis Breast solution. This study was performed at Radboud University Medical Center...

NIJMEGEN, the Netherlands – Aiosyn, a pioneering pathology software company specializing in AI-powered solutions for kidney disease and breast cancer, has integrated its glomerular quantification algorithm with Sectra’s diagnostic...

From Deciphex on LinkedIn: 🚨 Don’t Miss Our Upcoming Webinar! 🚨 Join us for the second webinar in our series with Charles River Laboratories, where we’ll reveal the results of a time and motion study on Patholytix Foresight!...

OR

platinum partners

gold partners

Silver Partners

Media Partners